Alireza Ghoreifi, MD
@alirezaghoreifi
Research Fellow @USC_Urology ▶️ @UroOnc Fellow @DukeUrology| @SIU_urology Innovators Committee| ECEB @Current_Urology| Review Editor @FrontUrology ⚽️🎬🎼
ID:1763739284
https://orcid.org/0000-0002-7368-7240 07-09-2013 18:15:09
749 Tweets
1,0K Followers
889 Following
Follow People
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺
Assoc. Prof @USC_Urology | Director @urology_AI | Chair @EAU_YAUroTech | PI @ICARUS_collab @AI_PRISMA @uroGPT @CANGARU_check | Board @eauesut @EAUrf |
Mohamad Allaf
Director, Dept of Urology; Johns Hopkins Medicine; Views are my own; RTs not endorsements
Ashish M. Kamat, MD, MBBS
Endowed Professor, Surgeon, Former Fellowship Director @MDAndersonNews | President, IBCG | Assoc Editor @EurUrolOncol | Views my own
Sia Daneshmand, M.D.
Professor of Urology and Oncology (Clinical Scholar) Director of Urologic Oncology Director of Clinical Research Urologic Oncology Fellowship Director USC
European Urology
The Platinum Journal | Official Journal of EAU @Uroweb | Ranked #1 in Urology & Nephrology | Editor @JimCatto | IF 23.4
Our paper will be accessible for free for 50 days through the link below provided by Journal of Urology!
🔗jurology.com/eprint/XIM2FT4…
Amer. Urol. Assn. Jennifer Regala
Our paper will be accessible for free for 50 days through the link below provided by Journal of Urology!
🔗jurology.com/eprint/XIM2FT4…
Amer. Urol. Assn. Jennifer Regala
Midline extraperitoneal #RPLND (primary or post chemo) reduces surgical morbidity, eliminates ileus with short hospital stay (contemporary 90% discharge POD #1) Saum Ghodoussipour Brian Hu Muhannad Alsyouf Sunil Patel MD Hamed Ahmadi MD DrBagrodia Rob Hamilton
The first report on 'Outpatient' Robotic PC-RPLND for testicular cancer presented at #AUA24
Desiree E Sanchez Farshad Sheybaee Moghaddam
Surgery by Dr. Hooman Djaladat USC Urology!
🎉🎊Congratulations to Sia Daneshmand, M.D. and team Muhannad Alsyouf Erika L. Wood, MD,MPH Leilei Xia for winning the BEST VIDEO presentation at #AUA24 on their work on EP-RPLND for testicular cancer.
USC Urology Amer. Urol. Assn.
Great discussion on the role of primary RPLND in stage I and low-volume metastatic GCT by Legend Sia Daneshmand, M.D.
USC Urology #AUA24
Ongoing Society of Urologic Oncology debate #AUA24
🤖 robot v 🔪 open rplnd for #testicularcancer
Scott Eggener debunks the myth of unique recurrence patterns after the robotic approach
Amer. Urol. Assn. YUO UChicago Urology
A great debate on LND in #UTUC between Dr. Hooman Djaladat and Phillip Pierorazio moderated by Angie Smith
Society of Urologic Oncology meeting at #AUA24
🙌always a pleasure to receive endorsement from your mentor!
Great talk on Robotic RNU by Dr. Hooman Djaladat
- Robotic RNU is safe.
- Offer the advantages of a minimally invasive approach without impairing the oncological outcomes.
− Robotics may enhance the utilization of LND.
USC Urology Amer. Urol. Assn. #AUA24
Thank you for highlighting our study.
Analysis after propensity score matching of MIS vs open Nx post-IO groups:
⬇️lower EBL, intra-op transfusion, LOS, and ICU admission
➡️Simillar 90-day complications and readmissions
Dr. Hooman Djaladat USC Urology #AUA24
